ImmuCell Corp. (ICCC)
6.57
+0.33
(+5.29%)
USD |
NASDAQ |
Jan 08, 16:00
7.33
+0.76
(+11.57%)
After-Hours: 20:00
ImmuCell EPS Diluted (Quarterly): -0.0154 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 1.717 |
| AbbVie, Inc. | 0.0993 |
| Precipio, Inc. | -0.0482 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1397M |
| Revenue (Quarterly) | 5.506M |
| Total Expenses (Quarterly) | 5.646M |
| Enterprise Value | 69.15M |
| Gross Profit Margin (Quarterly) | 42.92% |
| Profit Margin (Quarterly) | -2.54% |
| Earnings Yield | 3.94% |
| Operating Earnings Yield | 3.94% |
| Normalized Earnings Yield | 3.941 |